EMA press briefing to inform on CHMP discussion on booster doses
To view the broadcast please ensure you meet the YouTube requirements. To view the video in the highest quality, click on the 'Settings' symbol in the right-hand corner of the video player and select '720p' or a higher resolution. |
The European Medicines Agency (EMA) is holding a press briefing on Tuesday, 5 October 2021. As the Committee for Medicinal Products for Human Use (CHMP) will discuss third doses and booster doses for some COVID-19 vaccines at a meeting on Monday, 4 October, attendees have the opportunity to ask questions on the CHMP’s considerations as well as on EMA’s other COVID-19 activities.
Speakers:
- Marco Cavaleri (Head of Biological Health Threats and Vaccines Strategy)
- Fergus Sweeney (Head of Clinical Studies and Manufacturing Task Force)
- Georgy Genov (Head of Pharmacovigilance)
The press briefing will be moderated by Marie-Agnes Heine (Head of Communications).
The press briefing will be held in English. No translations will be provided.